Efficacy Evaluation of Neoadjuvant Chemotherapy in Breast Cancer by MRI

Figure 1

MRI image of triple-negative breast cancer. (a) Before NAC, T2W; (b) after NAC, T2WI; (c) before NAC, T1W1; (d) after NAC, T1W1; (e) before NAC, T1W1; (f) after NAC, T1W1; (g) before NAC, the TIC type; and (h) after NAC, the TIC type is a type I of progressive enhancement.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)